Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGINTERFERON BETA-1A for Maternal exposure timing unspecified: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 82 adverse event reports in the FDA FAERS database where PEGINTERFERON BETA-1A was used for Maternal exposure timing unspecified.

Most Reported Side Effects for PEGINTERFERON BETA-1A

Side Effect Reports % Deaths Hosp.
Influenza like illness 1,431 11.5% 2 174
Injection site erythema 1,041 8.4% 0 119
Multiple sclerosis relapse 945 7.6% 2 578
Fatigue 673 5.4% 2 142
Headache 587 4.7% 0 105
Pain 580 4.7% 2 111
Injection site reaction 569 4.6% 1 51
Device malfunction 567 4.6% 0 9
Multiple sclerosis 536 4.3% 14 153
Pyrexia 503 4.0% 4 135
Memory impairment 455 3.7% 1 45
Malaise 448 3.6% 3 101
Injection site pain 435 3.5% 0 35
Fall 406 3.3% 5 214
Drug dose omission 389 3.1% 0 12

Other Indications for PEGINTERFERON BETA-1A

Multiple sclerosis (11,105) Product used for unknown indication (817) Relapsing-remitting multiple sclerosis (390) Secondary progressive multiple sclerosis (11) Demyelination (7) Relapsing multiple sclerosis (6)

Other Drugs Used for Maternal exposure timing unspecified

VALPROATE (1,477) ADALIMUMAB (1,280) NATALIZUMAB (492) RITONAVIR (486) EMTRICITABINE\TENOFOVIR DISOPROXIL (333) LOPINAVIR\RITONAVIR (278) DIVALPROEX (254) INTERFERON BETA-1A (245) DIMETHYL (212) ATAZANAVIR (169)

Related Pages

PEGINTERFERON BETA-1A Full Profile All Maternal exposure timing unspecified Drugs PEGINTERFERON BETA-1A Demographics PEGINTERFERON BETA-1A Timeline